95 related articles for article (PubMed ID: 7697732)
21. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites.
Deterre P; Gelman L; Gary-Gouy H; Arrieumerlou C; Berthelier V; Tixier JM; Ktorza S; Goding J; Schmitt C; Bismuth G
J Immunol; 1996 Aug; 157(4):1381-8. PubMed ID: 8759717
[TBL] [Abstract][Full Text] [Related]
22. Properties of a novel gene isolated from a Hodgkin's disease cell line that is expressed early during lymphoid cell activation.
Bennett JS; Tredway TL; Dizikes GJ; Nawrocki JF
J Immunol; 1994 Mar; 152(5):2229-40. PubMed ID: 8133036
[TBL] [Abstract][Full Text] [Related]
23. T-cell activation. V. Anti-major histocompatibility complex class I antibody-induced activation and clonal abortion in Jurkat T-leukaemic cells.
Claesson MH; Dissing S; Tscherning T; Geisler C
Immunology; 1993 Mar; 78(3):444-8. PubMed ID: 8097490
[TBL] [Abstract][Full Text] [Related]
24. Evidence for coordinated induction and repression of ecto-5'-nucleotidase (CD73) and the A2a adenosine receptor in a human B cell line.
Napieralski R; Kempkes B; Gutensohn W
Biol Chem; 2003 Mar; 384(3):483-7. PubMed ID: 12715899
[TBL] [Abstract][Full Text] [Related]
25. CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes.
Takedachi M; Qu D; Ebisuno Y; Oohara H; Joachims ML; McGee ST; Maeda E; McEver RP; Tanaka T; Miyasaka M; Murakami S; Krahn T; Blackburn MR; Thompson LF
J Immunol; 2008 May; 180(9):6288-96. PubMed ID: 18424752
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
[TBL] [Abstract][Full Text] [Related]
27. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
Jin D; Fan J; Wang L; Thompson LF; Liu A; Daniel BJ; Shin T; Curiel TJ; Zhang B
Cancer Res; 2010 Mar; 70(6):2245-55. PubMed ID: 20179192
[TBL] [Abstract][Full Text] [Related]
28. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).
Thomson LF; Ruedi JM; Glass A; Moldenhauer G; Moller P; Low MG; Klemens MR; Massaia M; Lucas AH
Tissue Antigens; 1990 Jan; 35(1):9-19. PubMed ID: 2137649
[TBL] [Abstract][Full Text] [Related]
29. CD3-stimulated Jurkat T cells mediate IL-1 beta production in monocytic THP-1 cells. Role of LFA-1 molecule and participation of CD69 T cell antigen.
Manié S; Kubar J; Limouse M; Ferrua B; Ticchioni M; Breittmayer JP; Peyron JF; Schaffar L; Rossi B
Eur Cytokine Netw; 1993; 4(1):7-13. PubMed ID: 8490106
[TBL] [Abstract][Full Text] [Related]
30. IFN-beta protects from vascular leakage via up-regulation of CD73.
Kiss J; Yegutkin GG; Koskinen K; Savunen T; Jalkanen S; Salmi M
Eur J Immunol; 2007 Dec; 37(12):3334-8. PubMed ID: 18034430
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells.
Airas L; Niemelä J; Salmi M; Puurunen T; Smith DJ; Jalkanen S
J Cell Biol; 1997 Jan; 136(2):421-31. PubMed ID: 9015312
[TBL] [Abstract][Full Text] [Related]
32. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
[TBL] [Abstract][Full Text] [Related]
33. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells.
Barry F; Boynton R; Murphy M; Haynesworth S; Zaia J
Biochem Biophys Res Commun; 2001 Nov; 289(2):519-24. PubMed ID: 11716504
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of CD73 associates with T cell exhaustion in AML patients.
Kong Y; Jia B; Zhao C; Claxton DF; Sharma A; Annageldiyev C; Fotos JS; Zeng H; Paulson RF; Prabhu KS; Zheng H
J Hematol Oncol; 2019 Apr; 12(1):40. PubMed ID: 31014364
[TBL] [Abstract][Full Text] [Related]
35. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
[TBL] [Abstract][Full Text] [Related]
36. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
Signorelli KL; Watts LM; Lambert LE
Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
[TBL] [Abstract][Full Text] [Related]
37. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY
Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845
[TBL] [Abstract][Full Text] [Related]
38. CD73: a potent suppressor of antitumor immune responses.
Beavis PA; Stagg J; Darcy PK; Smyth MJ
Trends Immunol; 2012 May; 33(5):231-7. PubMed ID: 22487321
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of a soluble form of human CD73 with ecto-5'-nucleotidase activity.
Heuts DP; Weissenborn MJ; Olkhov RV; Shaw AM; Gummadova J; Levy C; Scrutton NS
Chembiochem; 2012 Nov; 13(16):2384-91. PubMed ID: 22997138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
